PUBLISHER: The Business Research Company | PRODUCT CODE: 1659270
PUBLISHER: The Business Research Company | PRODUCT CODE: 1659270
Non-invasive brain trauma monitoring devices are instruments designed to monitor brain activity, neural signals, and pressure levels around the brain without the need for invasive procedures. These devices serve to analyze blood flow rates in the brain's arteries and veins, particularly crucial in cases of brain trauma, epilepsy, and brain-related injuries.
The realm of non-invasive brain trauma monitoring devices, various types exist, including the non-invasive intracranial pressure monitor and the non-invasive cerebral edema dynamic monitor, among others. The non-invasive intracranial pressure monitor plays a critical role in managing diverse neurological conditions. This device is part of an invasive system, involving a ventricular catheter linked to an external strain gauge, although it presents several complexities. These devices find applications across cardiology, urology, nephrology, oncology, gastroenterology, and other specialized fields, utilized within hospitals, neurological centers, and by various end-users.
The non-invasive brain trauma monitoring devices market research report is one of a series of new reports from The Business Research Company that provides non-invasive brain trauma monitoring devices market statistics, including non-invasive brain trauma monitoring devices industry global market size, regional shares, competitors with a non-invasive brain trauma monitoring devices market share, detailed non-invasive brain trauma monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive brain trauma monitoring devices industry. This non-invasive brain trauma monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The non-invasive brain trauma monitoring devices market size has grown rapidly in recent years. It will grow from $8.68 billion in 2024 to $9.65 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to personalized medicine approach, focus on long-term monitoring, widespread adoption of wearables, signal sensitivity improvement, multimodal monitoring integration.
The non-invasive brain trauma monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $15.15 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to rise in awareness and diagnosis, collaborative research efforts, demand for long-term monitoring solutions, signal processing innovations, remote connectivity advancements. Major trends in the forecast period include miniaturization and wearable devices, advancements in sensor technology, focus on real-time monitoring, remote patient monitoring, non-invasive imaging techniques.
The increasing prevalence of neurological disorders and diseases is anticipated to boost the demand for non-invasive brain trauma monitoring devices. Neurological disorders are a significant category of non-communicable diseases (NCDs) that affect individuals' thoughts, emotions, behaviors, and injuries, including brain, spinal cord, and nerve injuries. Non-invasive brain trauma monitoring devices enable continuous patient monitoring, allowing physicians to assess critical levels and determine appropriate actions to mitigate severe trauma conditions. For example, in January 2024, the American Cancer Society, a U.S.-based nonprofit cancer advocacy organization, projected that new cases of brain cancer would reach 25,400 in 2024, up from 24,810 in 2023. Therefore, the growing incidence of neurological disorders and diseases will drive the market for non-invasive brain trauma monitoring devices.
The ascendancy of personalized medicine has significantly fueled the growth trajectory of non-invasive brain trauma monitoring devices. Personalized medicine, leveraging an individual's genetic profile for disease prevention, diagnosis, and treatment decisions, has spurred the demand for tailored monitoring approaches. This tailored strategy enhances precision and efficacy in monitoring, aligning with specific patient needs and responses. As of 2022, the Personalized Medicine Coalition projected that personalized medicines would constitute 34% of new drug approvals by the US Food and Drug Administration, underscoring the pivotal role of personalized medicine in propelling the market for these monitoring devices.
Technological advancement is a significant trend gaining traction in the non-invasive brain trauma monitoring device market. Leading companies in this sector are developing innovative technologies to bolster their market presence. For example, in May 2024, Canon Medical Systems, a Japan-based medical imaging and healthcare technology firm, launched the first installation of the Aquilion Serve SP CT scanner in the U.S., integrated with INSTINX, an AI-driven workflow automation system. This scanner aims to enhance imaging capabilities and improve patient care. Moreover, the INSTINX system serves as an AI-powered workflow automation tool that streamlines imaging processes, thereby optimizing efficiency and accuracy in clinical environments.
Major players in the non-invasive brain trauma monitoring devices sector are pioneering advanced technologies such as AI-enabled optical fiber sensor devices. These cutting-edge devices employ flexible silica-based optical fibers with four sensing films to simultaneously measure crucial biomarkers in cerebrospinal fluid. For instance, in August 2022, Imperial College London unveiled an AI-enabled, optical fiber sensor device specifically designed to measure multiple biomarkers of traumatic brain injury (TBI). Integrated with machine learning algorithms, this device predicts biomarker concentrations based on real-time data, potentially revolutionizing neurocritical care by significantly improving TBI monitoring and patient outcomes.
In November 2022, SonderMind, a digital behavioral health company situated in the United States, completed the acquisition of Total Brain for an undisclosed sum. This strategic move by SonderMind aims to provide their therapists with enhanced capabilities to track treatment outcomes, extend population health reporting services to enterprise clients, and deliver comprehensive solutions to insurers and healthcare organizations. Total Brain, based in the U.S., specializes in brain monitoring technologies.
Major companies operating in the non-invasive brain trauma monitoring devices market are Sophysa Ltd., Spiegelberg GmbH & Co. KG, Natus Medical Inc., Nihon Kohden Corporation, Philips Healthcare, Advanced Brain Monitoring, CAS Medical Systems Inc., Siemens AG, Compumedics Ltd., Medtronic Plc., Integra LifeSciences, Cadwell Industries Inc., Codman & Shurtleff Inc., Covidien PLC., Hitachi Medical Corporation, Koninklijke Philips N.V., NeuroLogica Corp., NeuroWave Systems Inc., Noraxon U.S.A, Sense Neuro Diagnostics, GE Healthcare, BrainScope Company Inc., Cerebrotech Medical Systems Inc., Neural Analytics Inc., Oculogica Inc., Ornim Medical Ltd.
North America was the largest region in the non-invasive brain trauma monitoring devices market share in 2024. The regions covered in the non-invasive brain trauma monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the non-invasive brain trauma monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The non-invasive brain trauma monitoring devices market consists of sales of monitoring devices, consumables, and accessories. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Non-Invasive Brain Trauma Monitoring Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on non-invasive brain trauma monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for non-invasive brain trauma monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The non-invasive brain trauma monitoring devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.